{
    "organizations": [],
    "uuid": "4e58625acf4dfad45576230467b771459588c676",
    "author": "cnbc.com",
    "url": "https://www.cnbc.com/2018/02/27/the-associated-press-five-prime-therapeutics-posts-4q-loss.html",
    "ord_in_thread": 0,
    "title": "Five Prime Therapeutics posts 4Q loss",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "SOUTH SAN FRANCISCO, Calif. (AP) _ Five Prime Therapeutics Inc. (FPRX) on Tuesday reported a loss of $29.2 million in its fourth quarter.\nThe South San Francisco, California-based company said it had a loss of $1.04 per share.\nThe results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.29 per share.\nThe biotech company that develops treatments targeting cancer and autoimmune diseases posted revenue of $13.2 million in the period.\nFor the year, the company reported that its loss widened to $150.2 million, or $5.38 per share. Revenue was reported as $39.5 million.\nFive Prime Therapeutics shares have declined 15 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $18.64, a decrease of 62 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on FPRX at https://www.zacks.com/ap/FPRX",
    "published": "2018-02-28T01:03:00.000+02:00",
    "crawled": "2018-02-28T01:27:32.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "south",
        "san",
        "francisco",
        "ap",
        "five",
        "prime",
        "therapeutic",
        "fprx",
        "tuesday",
        "reported",
        "loss",
        "million",
        "fourth",
        "quarter",
        "south",
        "san",
        "francisco",
        "company",
        "said",
        "loss",
        "per",
        "share",
        "result",
        "beat",
        "wall",
        "street",
        "expectation",
        "average",
        "estimate",
        "four",
        "analyst",
        "surveyed",
        "zacks",
        "investment",
        "research",
        "loss",
        "per",
        "share",
        "biotech",
        "company",
        "develops",
        "treatment",
        "targeting",
        "cancer",
        "autoimmune",
        "disease",
        "posted",
        "revenue",
        "million",
        "period",
        "year",
        "company",
        "reported",
        "loss",
        "widened",
        "million",
        "per",
        "share",
        "revenue",
        "reported",
        "million",
        "five",
        "prime",
        "therapeutic",
        "share",
        "declined",
        "percent",
        "since",
        "beginning",
        "year",
        "final",
        "minute",
        "trading",
        "tuesday",
        "share",
        "hit",
        "decrease",
        "percent",
        "last",
        "month",
        "story",
        "generated",
        "automated",
        "insight",
        "http",
        "using",
        "data",
        "zacks",
        "investment",
        "research",
        "access",
        "zacks",
        "stock",
        "report",
        "fprx",
        "http"
    ]
}